Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
International Urology and Nephrology|June 17, 2004
Can peritoneal dialysis be used as a long term therapy for end stage renal disease?Michele Giannattasio, Michele Buemi, Flavia Caputo, et al.
International Journal of Nephrology and Renovascular Disease|August 28, 2018
Takayasu's disease effects on the kidneys: current perspectivesGioacchino Li Cavoli, Giuseppe Mulè, Mario Giuseppe Vallone, et al.
Medicina|August 16, 2012
[Pulmonary fibrosis associated with anti-neutrophil cytoplasmic antibody positive vasculitis]Marcelo Fernández Casares, Alejandra González, Flavia Caputo, et al.
Clinical Rheumatology|May 28, 2014
Microscopic polyangiitis associated with pulmonary fibrosisMarcelo Fernandez Casares, Alejandra Gonzalez, Mariano Fielli, et al.
Bone|June 16, 2012
Prevalence and progression of cardiovascular calcifications in peritoneal dialysis patients: A prospective studyMaurizio Gallieni, Flavia Caputo, Armando Filippini, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|April 28, 2012
[Home hemodialysis and peritoneal dialysis compared]Giorgina Barbara Piccoli, Martina Ferraresi, Flavia Caputo, et al.
Clinical Kidney Journal|April 13, 2018
Clinical management of patients on peritoneal dialysis in Italy: results from the ATENA studyCarlo Crepaldi, Alessandro Possidoni, Flavia Caputo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 30, 2008
Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysisPieter Evenepoel, Rafael Selgas, Flavia Caputo, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 20, 2019
Long-term, prolonged-release tacrolimus-based immunosuppression in de novo kidney transplant recipients: 5-year prospective follow-up of the ADHERE study patientsOleg Rummo, Mario Carmellini, Nassim Kamar, et al.
Molecular Immunology|May 25, 2024
Integrative analysis of systemic lupus erythematosus biomarkers: Role of fecal hsa-mir-223-3p and gut microbiota in transkingdom dynamicsSofía Quesada, Ayelén Daiana Rosso, Florencia Mascardi, et al.
Pageof 2